Vaccine News and Research

Latest Vaccine News and Research

Preexisting flu immunity may offer baseline protection against avian influenza

Are seasonal flu antibodies also effective against avian flu? A team from the University of Geneva (UNIGE) has shown that a specific type of antibody associated with the former virus—already present throughout the population—may offer baseline protection against the latter.

10 Feb 2026

US cancer institute studying ivermectin’s ‘ability to kill cancer cells’

The National Cancer Institute, the federal research agency charged with leading the war against the nation's second-largest killer, is studying ivermectin as a potential cancer treatment, according to its top official.

10 Feb 2026

Large Swedish study finds COVID-19 vaccination unrelated to fertility or childbirth rates

A Swedish registry-based cohort study evaluated whether COVID-19 vaccination affected childbirth rates among women aged 18 to 45 years during the pandemic period. No statistically significant association was found between vaccination, childbirth, or recorded miscarriage rates, suggesting demographic and socioeconomic factors likely explain observed fertility trends.

8 Feb 2026

Binghamton University receives $2.5 million to develop a next-generation avian flu vaccine

Outbreaks of avian flu at U.S. poultry farms led to more than $1.5 billion in losses over the last two years and drove egg prices to all-time highs in 2025.

6 Feb 2026

New analysis reveals hidden complexity in the vaginal microbiome

For decades, gynecological tests have relied on a simplified view of the vaginal microbiome, categorizing bacteria as either "good" or "bad."

6 Feb 2026

New DNA-based vaccine scaffolds boost targeted immune responses to HIV

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In most vaccines, HIV proteins are attached to a larger protein scaffolding that mimics a virus.

6 Feb 2026

Griffith researchers on the cusp of new vaccine to prevent chikungunya

Griffith University researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue.

6 Feb 2026

Weak governance hinders One Health outbreak response in Africa

Across Africa, One Health is endorsed at the top but often breaks down where outbreaks start, writes Albert Ansah.

5 Feb 2026

Expanded vaccine supply allows resumption of cholera prevention campaigns

Global cholera vaccine supply has now increased to a level sufficient to allow the resumption of life-saving preventive campaigns for the first time in over three years, Gavi, the Vaccine Alliance, UNICEF, and the World Health Organization (WHO) announced today.

5 Feb 2026

Study reveals evidence of silent mpox exposure in healthy Nigerians

New evidence suggests that mpox may be circulating quietly among healthy Nigerians, with some infections occurring without the symptoms that typically trigger detection by health authorities.

5 Feb 2026

Gut microbial butyrate enhances mucosal vaccine antibody responses

A research team from POSTECH and ImmunoBiome in Korea, led by Professor Sin-Hyeog Im, has uncovered a new mechanism showing how butyrate-a short-chain fatty acid produced by gut commensal bacteria-enhances T follicular helper (Tfh) cell activity to promote antibody production and strengthen mucosal vaccine efficacy.

4 Feb 2026

Breakthrough enables continuous laboratory growth of human norovirus

Researchers at Baylor College of Medicine report in Science Advances a breakthrough in human norovirus (HuNoV) research.

4 Feb 2026

COVID vaccination not linked to reduced childbirth

COVID-19 vaccination is not the cause behind a decrease in childbirth, according to a study from Linköping University, Sweden.

4 Feb 2026

Poll: Many adults over 50 skip flu and COVID vaccines

This winter's brutal flu season isn't over, and COVID-19 cases have risen recently too. But a new poll taken in recent weeks shows that vaccination against both viruses lags among people 50 and over, and the national survey reveals key reasons why.

3 Feb 2026

Single-dose HIV vaccine candidate induces neutralizing antibodies

Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single immunization in nonhuman primates.

3 Feb 2026

Six years after COVID-19: Lessons learned and pandemic preparedness

Six years ago, the Director-General of the World Health Organization sounded the highest global alarm available under international law at the time, declaring the outbreak of a new coronavirus disease (later known as COVID-19) a Public Health Emergency of International Concern (PHEIC).

3 Feb 2026